Ultra-hypofractionation for node-positive prostate cancer: pushing boundaries and redefining standards.
Options
Date of Publication
May 8, 2025
Publication Type
Article
Division/Institute
Author
Le Guévelou, Jennifer | |
Jeandin, Mathilde | |
Angrisani, Antonio | |
Bosetti, Davide Giovanni | |
Zilli, Thomas |
Subject(s)
Series
Prostate Cancer and Prostatic Diseases
ISSN or ISBN (if monograph)
1476-5608
1365-7852
Publisher
Springer Nature [academic journals on nature.com]
Language
English
Publisher DOI
PubMed ID
40341654
Description
Radiotherapy is a cornerstone in the management of node-positive prostate cancer. Advances in imaging modalities and radiation therapy techniques have led to the evolution of treatment standards for this patient population. This review aims to explore the therapeutic advancements of the past decade, with a focus on the role of ultra-hypofractionated radiotherapy in node-positive prostate cancer.